Prescription versus pharmacy rules
Know the substance.
Then check the rules.
A substance can be real while the evidence and the rules still limit its use. Keep those questions apart.
A real substance, made in a lab.
BPC-157 is made in a lab and contains 15 amino acids, the small parts that link up to form proteins.
Its name comes from Body Protection Compound.
Source · FDA’s ingredient reviewThere is no approved treatment to name.
FDA is short for Food and Drug Administration, the US drug agency.
By September 28, 2026, FDA had approved no medicine containing BPC-157 for any use.
At the September 28, 2026, check, FDA’s review also reported no approved BPC-157 product anywhere in the world.
Source · FDA’s approval findingsA prescription does not let a pharmacy make BPC-157.
Compounding is when a medicine is made to order by a pharmacist or doctor.
As checked on September 26, 2026, US rules did not permit a pharmacy to make BPC-157 from raw ingredients for a named patient.
Source · FDA’s raw-ingredient rulesAs of September 26, 2026, compounded medicines had no FDA approval. FDA had not reviewed their safety, quality, or effects before they went on the market.
Source · FDA’s compounding explanationWithdrawing a request gives no permission to use BPC-157.
Groups asked FDA to add BPC-157 to a list of raw ingredients pharmacies may use to make medicines.
FDA’s page lists BPC-157 under requests those groups took back.
The page says its information was current as of April 22, 2026.
At the September 28, 2026, check, that entry did not mean FDA had approved BPC-157 or given pharmacies permission to use it.
Source · FDA’s table of requests taken backIf someone offers a prescription, ask which rule they believe lets the pharmacy make it. Ask to see the rule they rely on.